Health & Wellness
‘We built a brain roadmap for each person’: New AI-driven tools help decode Alzheimer’s disease at the cellular level
Identifying the cells connected with Alzheimer’s symptoms could result in new treatments for the disease.
First drug to treat Alexander disease approved by the FDA after three decades of research at UW–Madison
The drug is the first and only disease-modifying treatment for the rare neurological disease.
Study linking environmental factors and Alzheimer’s disease awarded NIH funding
The nationwide study led by the UW School of Medicine and Public Health explores the relationship between Alzheimer’s disease, environmental factors and lifetime experiences.
Health & Wellness Events
October
- 16
- 17
-
17
Arboretum Curtis Prairie Area9:00 am, Meet at Visitor Center, UW–Madison Arboretum
- 17
- 17
-
17
6:00 pm
- 18